QuantSeq 3' mRNA-Seq
Most cost-efficient and reliable solution for gene expression profiling.
- Save significantly on sequencing costs due to 3' mRNA-Seq approach
- Compatible with low input and low-quality samples
- Specific solutions for FFPE and whole blood samples
- Data analysis is included on Kangooroo
- Available as service at Lexogen
“We have been using QuantSeq for over 5 years to profile samples that we have found previously difficult to target, such as formalin fixed, paraffin embedded (FFPE) samples. We have found that QuantSeq allows good reproducibility, low sample input requirements and rapid turnaround, allowing us to make the most of these precious samples.”
Andrew Beggs
Professor of Cancer Genetics & Surgery, Institute of Cancer and Genomic Sciences University of Birmingham, UK
About Lexogen
Lexogen is a biotech company focusing on RNA and complete transcriptome studies using next generation sequencing technologies.
We have been at the forefront of RNA research since 2007, and our technologies and products are being used by thousands of scientists all over the world. “Lexo” in Greek means “word”, and Lexogen stands for the word of genes, which is the transcriptome. We strive to be the pioneers in this fascinating field of RNA science, and together with the fastest-growing technology of the past years, the next generation sequencing (NGS), we are sure that we can make a big contribution to the world.